|
|
|
|
Subchronic and Chronic Toxicity
(Other than Carcinogenicity) |
|
Subchronic [RfD]: (see comment) |
3E-3 mg/kg/day |
|
Uncertainty Factor: |
10 |
|
Route: |
Oral: capsule |
|
Target Organ / Critical Effect: |
Blood / Decreased cholinesterase activity |
|
Species |
Effect Level |
Dose |
Experiment Length |
Human |
NOEL |
0.03 mg/kg/day |
20 days or 9 days |
|
References |
1972 | Dow Chemical Company. 1972. Confidential business information, unpublished study. Accession NO 112118. |
1984 | U.S. EPA. 1984. Health and environmental effects profile for Chlorpyrifos and Chloropyrifos-Methyl. Prepared by the Office of Health and Environmental Assessment, Environmental Criteria and Assessment Office, Cincinnati, OH for the Office of Solid Waste and Emergency Response, Washington, DC |
1986 | U.S. EPA. 1986. RfD/RfC Work Group. |
|
Subchronic [RfD] Comments: |
The chronic oral RfD was adopted as the subchronic oral [RfD]. |
|